New Diabetes Drug May Help Prevent Alzheimer's Disease
Read More:
Diabetes Type II,
Glp-1,
Dementia,
Liraglutide,
Brain,
Alzheimer's Disease,
Insulin,
Health,
Healthy Living News
Novo Nordisk, announced that their drug, liraglutide, which will carry the trade name Victoza, has been approved by the FDA for use in the United States for the treatment of Diabetes Type II.
Scott Mendelson, M.D. | Posted 11.17.2011